Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Domenica Taruscio, M.D. is the Director of the Italian National Centre for Rare Diseases at the Italian National Institute of Health (Rome, Italy). She holds a M.D. and a specialization in Histopathology from the University of Bologna, a master in Bioethics from the Rome University) a has carried out post-doctoral studies in Human Genetics at Yale University (CT-USA). She is Past-President (2010-2012) of ICORD (International Conference for Rare Diseases and Orphan Drugs) Society; has been the Italian COMP (Committee for Orphan Medicinal Products) Member at EMA (2000-2009); a member of the former European Rare Diseases Task Force, EUCERD (European Union Committee of Experts on Rare Diseases) and a Member of the “Health Research” Advisory Group. Dr Taruscio is a Member of the Interdisciplinary Committee of IRDiRC, a member of the Advisory European Molecular Genetics Quality Network management board, a Member of the Management Board of the European Molecular Genetics Quality Network (EMQN), and she has been member of the advisory board of Eurogentest (NoE). She has been newly appointed to the European Commission Experts Group on Rare Diseases. Scientific Coordinator of numerous EU and international projects on rare diseases such as: EUROPLAN (European Project for Rare Diseases National Plans Development); EPIRARE (European Platform for Rare Disease Registries); RARE-Bestpractices; contributes as WP leader to RD-Connect, Advance-HTA, BURQ-OL, E-RARE, EUROCAT Joint Action, to name few. For decades, her efforts have been mainly directed to face the many and complex challenges posed by rare diseases and has addressed them from various facets: from science to society, from experimental research to public health, from training health professionals to the empowerment of patients and their families - having always at heart the quality of life of rare disease patients and of their families.